Dr Marianne W. Mureithi, Director of the KAVI-Institute of Clinical Research (KAVI-ICR)  at the University of Nairobi, is a Co-Investigator on a newly announced CAD 2 million (5-year) international team grant funded by the Canadian Institutes of Health Research (CIHR) under its Bringing Biology to Cancer Prevention programme.

The study will examine how inflammation and hormonal changes influence HPV persistence and cervical cancer risk in menopausal women.

KAVI-Institute of Clinical Research is proud to highlight the participation of our researcher, Joel Musando, at the IDA Symposia, held in Stellenbosch, South Africa (26–30 January 2026). The symposium focused on infectious diseases in Africa and capacity building in grant writing, bringing together MSc and PhD trainees alongside leading scientists from across the continent.

The Kenya AIDS Vaccine Initiative–Institute of Clinical Research (KAVI-ICR) recently hosted a high-level delegation from the University of Nairobi’s Advancement and Institutional Development and Engineering Science Complex Project (ESC), marking an important step in advancing innovation-driven academic–industry partnerships.

The KAVI-Institute of Clinical Research (KAVI-ICR) team from the University of Nairobi paid a courtesy visit to Migori County Referral Hospital as part of ongoing efforts to strengthen partnerships between academic research institutions and county health facilities.

On Friday, 30 January 2026, KAVI-Institute of Clinical Research opened its doors to collaborators and prospective partners during an Open House held alongside the University of Nairobi Collaborative HIV/STI/Reproductive Health Research Group Annual Meeting.

Nairobi, Kenya — The International Vaccine Institute (IVI), in partnership with the KAVI–Institute of Clinical Research (KAVI-ICR) at the University of Nairobi, has officially launched a Phase 2 clinical trial of a novel cholera conjugate vaccine. This study is now actively recruiting adults and children from Nairobi City County to take part in what could be a significant advance in cholera prevention.

The University of Nairobi's annual STD/HIV/SRH Collaborative Research Group meeting kicked off on Monday, January 26, 2026, at the Serena Hotel, bringing together leading scientists, public health experts, and stakeholders. The opening days set a powerful tone, emphasizing not just scientific presentation but crucial dialogue on the future of research in a changing global landscape.

Day 1: Setting the Stage for Strategic Dialogue

On 11th December 2025, the KAVI-ICR family came together for an exciting and energising team-building experience at Nkasiri Adventure Park. The day promised connection, fun, and renewal, and it certainly delivered.

KAVI-Institute of Clinical Research (KAVI-ICR) was privileged to have been represented at the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE) annual consortium meeting (ACM) held in Kigali, Rwanda, at the Marriott Hotel from the 3rd to the 7th of November, 2025. SANTHE aims to shape and drive locally relevant basic, clinical and translational research in Africa, with all of the research conducted under SANTHE being led by African scientists.

Last week on Thursday, 13th November, KAVI–Institute of Clinical Research was honoured to host Dr Kundai Chinyenze, IAVI’s Strategic Partnership & Regional Director, together with Polet Juma (Operations Director & Kenya Country Lead) and the IAVI Kenya team.